HIV pre-exposure prophylaxis (PrEP) has been a proven HIV prevention modality for almost a decade, yet women, who make up 20% of new HIV cases annually, have not been prioritized in these efforts. Join us as we discuss the basics of PrEP, which medications are available now, what patients would get the most benefit from it, and how to conduct a good sexual history, initiate, and conduct follow-up visits for PrEP.

Today we talk to Dr. David Malebranche and Ariel Watriss on how to integrate the latest CDC HIV prevention guidelines into your practice. We discuss the science and effectiveness of PrEP,  the patients who may benefit the most from PrEP, and describe the baseline and follow-up labs needed to administer PrEP to patients. We also discuss how you can integrate PrEP into your current clinical practice and how to design a clinical flow template to assess needs and indications for PrEP